fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search

A New Collaboration Agreement Between Sheba and Regeneron is set to Advance Patient Care

Sheba - Regeneron
The cooperation will focus on enhancing oncology research in an effort to accelerate the development of potential novel therapeutics.

In line with Sheba’s commitment to providing ‘hope without boundaries,’ improving care, and supporting its patients in combating even the most complex conditions, we are always on the lookout for impactful collaborations, which are key to making a positive impact on healthcare.

With that in mind, Sheba is proud to report the signing of a new partnership with Regeneron, a leading global biotechnology company. Through collaboration, Sheba and Regeneron will advance oncology research to develop new therapeutics for the benefit of patients worldwide.

“We are excited and proud to partner with Regeneron to accelerate clinical research and to enhance patient access to novel treatments,” says Prof. Yitshak Kreiss, Director General of Sheba Medical Center. “This latest agreement exemplifies our mutual desire to improve patient outcomes with an emphasis on creating a better quality of life.”

Led by physician-scientists for nearly 35 years, Regeneron’s unique ability to consistently translate science to clinical practice has led to nine FDA-approved treatments and numerous product candidates in development.

“The Regeneron team is pleased to collaborate with Sheba to accelerate clinical studies of novel oncology therapeutics for patients in need,” stated Dr. David Weinreich, Executive Vice President, Global Clinical Development of Regeneron. “As we work to turn innovative science into vital medicines, we will partner with centers of excellence like Sheba that have established best practice clinical trial processes. We will also share knowledge through programs such as our joint Post-Doctoral Research program, because we know that fighting cancer requires cooperation from the best minds around the world.”    While Sheba continually works to improve the-first class medicine and services provided, we never lose sight of what matters – the individual, and are deeply committed to delivering patient-centric, compassionate, and personalized care. As part of this collaboration, Regeneron will partner with the Precision Medicine Hub of Sheba’s ARC (Accelerate, Redesign and Collaborate) Innovation Center, which is devoted to developing advanced, personalized treatments through the use of genomic, proteomic, microbiome, and other data. To that end, Regeneron is also set to join Sheba’s HealthTech Valley, a growing global ecosystem focused on transforming healthcare by bringing together academia, industry, and medicine.

Related
EBMT 50th Anniversary: Prof. Arnon Nagler Shares Expertise
Prof. Nagler attended the EBMT's 50th meeting, discussing bone marrow transplantation, donor selection, and treatment optimization in a series of interviews.
Read More
A Heartfelt Journey: Baby Marios’s Triumph Over Adversity
Six-month-old Marios Fesas, born in Cyprus, embarked on a harrowing journey when diagnosed with a critical heart defect just days after birth. With unwavering hope,…
Read More
Designing for Wellness: Place2Heal's Vision for Pediatric Care
At Sheba’s Edmond and Lily Safra Children’s Hospital, comforting and preparing young patients for medical procedures remains integral to their care. The formidable nature of…
Read More